NCT05668650 2024-07-16Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLCLaboratorio Elea Phoenix S.A.Phase 3 Recruiting174 enrolled